Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 524 results for "cadila pharma"

Pharma shares in demand; Healthcare index hits new high

Sun Pharma, Ranbaxy, Dr Reddy's Lab, Lupin, Glenmark, Wockhardt and Cadila Healtchare gained 1-8% on BSE. Business Standard, 2 days ago
Healthcare and pharma: Fear of pricing action Financial Express, 3 weeks ago

17 images for cadila pharma

Rediff.com, 1 week ago
Bio Spectrum Asia, 1 week ago
Money Control, 1 month ago
Rediff.com, 4 months ago
Financial Express, 6 months ago
Sify, 5 months ago
Moneycontrol.com, 5 months ago
Moneycontrol.com, 5 months ago
Rediff.com, 5 months ago
NDTV Profit, 6 months ago

Prefer Aurobindo, Cadila, Divis, Torrent Pharma: Sharekhan

Sharekhan has come out with its Q1FY2015 pharma earnings preview. According to the research firm, Aurobindo Pharma, Cadila Healthcare, Divis Laboratories and Torrent Pharma are the preferred picks from the Q1FY2015 results perspective.
 Money Control2 weeks ago Sharekhan positive on pharma; prefers Aurobindo, Torrent  Moneycontrol.com1 week ago

Budget addressed the current challenges facing the Indian economy: Cadila Pharma

It's earnings season. www.indiainfoline.com, a part of the IIFL Group, presents you real-time, comprehensive, and in-depth analysis of company earnings to give you that investment edge. The 'Results Calendar' helps you keep track of all important results. The ...
 India Infoline2 weeks ago Setting up labs a noteworthy step: Cadila Pharma  Business Line2 weeks ago

Cadila Pharma takes various initiatives on World Environment Day

Aims to increase awareness towards the environment With an aim to increase awareness towards environment, Ahmedabad-based Cadila Pharmaceuticals recently celebrated World Environment Day by launching a unique Save Paper Campaign to reduce ...
 Express Pharma1 month ago
Business Standard

Zydus Cadila Q4 net dips 1.8%

Ahmedabad-based pharma major Cadila Healthcare ( Zydus Cadila) posted a slight dip (1.8%) in net profit for the quarter ended March 31, 2014 at Rs 216.6 crore against Rs 220.7 crore in the corresponding quarter last fiscal. Total Income for the quarter ...
 Business Standard2 months ago Cadila Healthcare spurts on commencing Phase 3 trials of Lipaglyn  Arihant Capital1 month ago Cadila Healthcare to present molecule ZYDPLA1 at the ICE/ENDO 2014  FirstWord Pharma1 month ago Cadila Healthcare net falls by 8.7% in Q4, dividend at 180%  PharmaBiz2 months ago
Rediff.com

Drug makers seek out-of-court settlement in clinical trial cases

Related to : Lupin Ltd,Cadila Healthcare Ltd,Sun Pharmaceuticals Industries Ltd Lupin Ltd BSE 09 Jun 14 | 12:00 AM 956.70 8.95 (0.94%) NSE 09 Jun 14 | 12:00 AM 957.60 9.9 (1.04%) In order to keep pace with the government's ...
 Smart Investor1 month ago
[x]  

Pankaj Patel passes on reigns to son at Zydus Wellness

Pankaj R Patel, the chairman and managing director of pharma major Cadila Healthcare Ltd has decided to pass on the reigns of the personal care products company under its umbrella Zydus Wellness Ltd to his son Sharvil P Patel who will now take over ...
 Business Standard1 week ago Pankaj Patel passes on baton to son at Zydus Wellness  Smart Investor1 week ago

Poll verdict a dawn of new hope: Cadila Pharma

It's earnings season. www.indiainfoline.com, a part of the IIFL Group, presents you real-time, comprehensive, and in-depth analysis of company earnings to give you that investment edge. The 'Results Calendar' helps you keep track of all important results. The ...
 India Infoline2 months ago

Pharma firms go to court over new price controls

Major Indian pharmaceutical companies have filed a petition in the High Court in Mumbai protesting the price cuts ordered by the National Pharmaceutical Pricing Authority (NPPA) a fortnight back, which they feel would be detrimental to industry ...
 The Hindu1 day ago

Pharma firms go to HC against use of special power for price cuts

Leading drug makers have approached the high court in Mumbai, raising concerns against the latest price cuts ordered by the National Pharmaceutical Pricing Authority (NPPA) by using provisions provided for extraordinary circumstances. Indian ...
 Business Standard India2 days ago Drug firms approach Bombay HC against recent price cuts  Smart Investor2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less